| Year |
Citation |
Score |
| 2019 |
Sikander M, Malik S, Khan S, Kumari S, Chauhan N, Khan P, Halaweish FT, Chauhan B, Yallapu MM, Jaggi M, Chauhan SC. Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer). Cells. 9. PMID 31906106 DOI: 10.3390/Cells9010103 |
0.339 |
|
| 2019 |
Mahnashi M, Elgazwi SM, Ahmed MS, Halaweish FT. Cucurbitacins inspired organic synthesis: Potential dual inhibitors targeting EGFR - MAPK pathway. European Journal of Medicinal Chemistry. 173: 294-304. PMID 31022583 DOI: 10.1016/J.Ejmech.2019.04.018 |
0.333 |
|
| 2019 |
Abou-Salim MA, Shaaban MA, Abd El Hameid MK, Elshaier YAMM, Halaweish F. Design, synthesis and biological study of hybrid drug candidates of nitric oxide releasing cucurbitacin-inspired estrone analogs for treatment of hepatocellular carcinoma. Bioorganic Chemistry. 85: 515-533. PMID 30807895 DOI: 10.1016/J.Bioorg.2019.01.068 |
0.402 |
|
| 2019 |
Sikander M, Malik S, Hafeez BB, Kumari S, Khan S, Apraku J, Mandil H, Massey AE, Ganju A, Khan P, Halaweish FT, Chauhan SC, Jaggi M. Abstract 4809: Bromo-ormeloxifene inhibits epithelial mesenchymal transitionviatargeting β-catenin signaling pathways in cervical cancer cells Cancer Research. 79: 4809-4809. DOI: 10.1158/1538-7445.Am2019-4809 |
0.344 |
|
| 2018 |
Ismail RSM, Abou-Seri SM, Eldehna WM, Ismail NSM, Elgazwi SM, Ghabbour HA, Ahmed MS, Halaweish FT, Abou El Ella DA. Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells. European Journal of Medicinal Chemistry. 155: 782-796. PMID 30047410 DOI: 10.1016/J.Ejmech.2018.06.024 |
0.355 |
|
| 2018 |
Gurusamy N, Alsayari A, Halaweish F. The role of cucurbitacins in combating cancers: A mechanistic review Pharmacognosy Reviews. 12: 157. DOI: 10.4103/Phrev.Phrev_17_18 |
0.368 |
|
| 2018 |
Sikander M, Malik S, Hafeez BB, Mandil H, Halaweish FT, Jaggi M, Chauhan SC. Abstract 2934: Cucurbitacin D enhances the therapeutic efficacy of docetaxel via targeting cancer stem cells and miR-145 Cancer Research. 78: 2934-2934. DOI: 10.1158/1538-7445.Am2018-2934 |
0.335 |
|
| 2017 |
Hafeez BB, Ganju A, Sikander M, Kashyap VK, Hafeez ZB, Chauhan N, Malik S, Massey AE, Tripathi MK, Halaweish FT, Zafar N, Singh MM, Yallapu MM, Jaggi M, Chauhan SC. Ormeloxifene suppresses prostate tumor growth and metastatic phenotypes via inhibition of oncogenic β-catenin signaling and EMT progression. Molecular Cancer Therapeutics. PMID 28615299 DOI: 10.1158/1535-7163.Mct-17-0157 |
0.324 |
|
| 2017 |
Elshaier YAMM, Shaaban MA, Abd El Hamid MK, Abdelrahman MH, Abou-Salim MA, Elgazwi SM, Halaweish F. Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma. Bioorganic & Medicinal Chemistry. 25: 2956-2970. PMID 28487127 DOI: 10.1016/J.Bmc.2017.03.002 |
0.396 |
|
| 2017 |
Ahmed MS, El-Senduny F, Taylor J, Halaweish FT. Biological Screening of Cucurbitacin Inspired Estrone Analogs Targeting Mitogen Activated Protein Kinase (MAPK) Pathway. Chemical Biology & Drug Design. PMID 28171685 DOI: 10.1111/Cbdd.12963 |
0.338 |
|
| 2017 |
Sikander M, Hafeez BB, Malik S, Ganju A, Halaweish FT, Yallapu MM, Chauhan SC, Jaggi M. Abstract 3224: Cucurbitacin D inhibits prostate tumor growth via targeting glucose metabolism Cancer Research. 77: 3224-3224. DOI: 10.1158/1538-7445.Am2017-3224 |
0.324 |
|
| 2017 |
Arjaibi HM, Ahmed MS, Halaweish FT. Mechanistic investigation of hepato-protective potential for cucurbitacins Medicinal Chemistry Research. 26: 1567-1573. DOI: 10.1007/S00044-017-1872-3 |
0.36 |
|
| 2016 |
Sikander M, Hafeez BB, Malik S, Alsayari A, Halaweish FT, Yallapu MM, Chauhan SC, Jaggi M. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer. Scientific Reports. 6: 36594. PMID 27824155 DOI: 10.1038/Srep36594 |
0.351 |
|
| 2016 |
Sikander M, Hafeez BB, Halaweish FT, Yallapu MM, Jaggi M, Chauhan SC. Abstract 3081: Novel cucurbitacin analogue Cuc D exhibits potent anti-cancer activity in cervical cancer Cancer Research. 76: 3081-3081. DOI: 10.1158/1538-7445.Am2016-3081 |
0.372 |
|
| 2015 |
El-Senduny FF, Badria FA, El-Waseef AM, Chauhan SC, Halaweish F. Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26242260 DOI: 10.1007/S13277-015-3773-8 |
0.355 |
|
| 2015 |
Maher DM, Khan S, Nordquist JL, Ebeling MC, Bauer NA, Kopel L, Singh MM, Halaweish F, Bell MC, Jaggi M, Chauhan SC. Ormeloxifene efficiently inhibits ovarian cancer growth. Cancer Letters. 356: 606-12. PMID 25306892 DOI: 10.1016/J.Canlet.2014.10.009 |
0.318 |
|
| 2015 |
Sikander M, Khan S, Chauhan N, Zaman MS, Yallapu MM, Halaweish FT, Chauhan B, Malik S, Jaggi M, Chauhan SC. Abstract 4468: Anticancer activity of novel cucurbitacin analogue in pancreatic cancer Cancer Research. 75: 4468-4468. DOI: 10.1158/1538-7445.Am2015-4468 |
0.353 |
|
| 2015 |
Khan S, Chauhan N, Yallapu MM, Ebeling MC, Balakrishna S, Ellis RT, Thompson PA, Behrman SW, Zafar N, Singh MM, Halaweish FT, Jaggi M, Chauhan SC. Abstract 4392: Generation of a novel ormeloxifene nanoparticle formulation for pancreatic cancer treatment Cancer Research. 75: 4392-4392. DOI: 10.1158/1538-7445.Am2015-4392 |
0.3 |
|
| 2014 |
Ahmed MS, Kopel LC, Halaweish FT. Structural optimization and biological screening of a steroidal scaffold possessing cucurbitacin-like functionalities as B-Raf inhibitors. Chemmedchem. 9: 1361-7. PMID 24682977 DOI: 10.1002/Cmdc.201300523 |
0.307 |
|
| 2014 |
Ahmed MS, Halaweish FT. Cucurbitacins: potential candidates targeting mitogen-activated protein kinase pathway for treatment of melanoma. Journal of Enzyme Inhibition and Medicinal Chemistry. 29: 162-7. PMID 23368732 DOI: 10.3109/14756366.2012.762646 |
0.33 |
|
| 2014 |
Sikander M, Zaman MS, Chauhan N, Yallapu MM, Khan S, Halaweish FT, Chauhan B, Jaggi M, Chauhan SC. Abstract 2714: A multi-targeted approach for pancreatic cancer treatment by a novel cucurbitacin analogue Cancer Research. 74: 2714-2714. DOI: 10.1158/1538-7445.Am2014-2714 |
0.347 |
|
| 2012 |
Gibson KA, Reese RN, Halaweish FT, Ren Y. Isolation and characterization of a bactericidal withanolide from Physalis virginiana. Pharmacognosy Magazine. 8: 22-8. PMID 22438659 DOI: 10.4103/0973-1296.93307 |
0.336 |
|
| 2012 |
Baruah M, Huntimer ED, Ahmed MS, Hoppe AD, Halaweish FT. Selective BODIPY® based fluorescent chemosensor for imaging Pb 2+ ion in living cells Tetrahedron Letters. 53: 4273-4275. DOI: 10.1016/J.Tetlet.2012.05.092 |
0.691 |
|
| 2011 |
Bartalis J, Halaweish FT. In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines. Bioorganic & Medicinal Chemistry. 19: 2757-66. PMID 21459003 DOI: 10.1016/J.Bmc.2011.01.037 |
0.731 |
|
| 2010 |
Dean SW, Mercer EJ, Halaweish FT. Biodiesel Synthesis via Recyclable Heterogeneous Catalyst: Titanium Niobate Nanosheet Journal of Astm International. 7: 102659. DOI: 10.1520/Jai102659 |
0.704 |
|
| 2010 |
Mercer EJ, Halaweish F. Determination of Free Glycerol in Biodiesel via Solid-Phase Extraction and Spectrophotometric Analysis Journal of the American Oil Chemists' Society. 88: 655-659. DOI: 10.1007/S11746-010-1707-6 |
0.719 |
|
| 2007 |
Jain S, Shirode A, Yacoub S, Barbo A, Sylvester PW, Huntimer E, Halaweish F, El Sayed KA. Biocatalysis of the anticancer sipholane triterpenoids. Planta Medica. 73: 591-6. PMID 17486535 DOI: 10.1055/S-2007-967188 |
0.727 |
|
| 2007 |
Zhang D, Halaweish FT. Isolation and characterization of ribosome-inactivating proteins from Cucurbitaceae. Chemistry & Biodiversity. 4: 431-42. PMID 17372945 DOI: 10.1002/Cbdv.200790035 |
0.712 |
|
| 2006 |
Huntimer ED, Halaweish FT, Chase CC. Proliferative activity of Echinacea angustifolia root extracts on cancer cells: Interference with doxorubicin cytotoxicity. Chemistry & Biodiversity. 3: 695-703. PMID 17193302 DOI: 10.1002/Cbdv.200690071 |
0.728 |
|
| 2006 |
Kronberg SL, Halaweish FT, Hubert MB, Weimer PJ. Interactions between Euphorbia esula toxins and bovine ruminal microbes. Journal of Chemical Ecology. 32: 15-28. PMID 16525867 DOI: 10.1007/S10886-006-9348-9 |
0.316 |
|
| 2005 |
Chen YG, Wu ZC, Gui SH, Lv YP, Liao XR, Halaweish F. Lignans from Schisandra hernyi with DNA cleaving activity and cytotoxic effect on leukemia and Hela cells in vitro. Fitoterapia. 76: 370-3. PMID 15893434 DOI: 10.1016/J.Fitote.2005.03.012 |
0.332 |
|
| 2005 |
Bartalis J, Halaweish FT. Relationship between cucurbitacins reversed-phase high-performance liquid chromatography hydrophobicity index and basal cytotoxicity on HepG2 cells. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 818: 159-66. PMID 15734155 DOI: 10.1016/J.Jchromb.2004.12.020 |
0.729 |
|
| 2004 |
Halaweish FT, Huntimer E, Khalil AT. Polyoxypregnane glycosides from Caralluma retrospiciens. Phytochemical Analysis : Pca. 15: 189-94. PMID 15202604 DOI: 10.1002/Pca.767 |
0.682 |
|
| 2004 |
Chen YG, Hai LN, Liao XR, Qin GW, Xie YY, Halaweish F. Ananosic acids B and C, two new 18(13-->12)-abeo-lanostane triterpenoids from Kadsura ananosma. Journal of Natural Products. 67: 875-7. PMID 15165154 DOI: 10.1021/Np0340302 |
0.331 |
|
| 2004 |
Chen YG, Wu ZC, Lv YP, Gui SH, Wen J, Liao XR, Yuan LM, Halaweish F. Triterpenoids from Schisandra henryi with cytotoxic effect on leukemia and Hela cells in vitro. Archives of Pharmacal Research. 26: 912-6. PMID 14661856 DOI: 10.1007/Bf02980199 |
0.426 |
|
| 2003 |
Zhao C, Liu Q, Halaweish F, Shao B, Ye Y, Zhao W. Copacamphane, picrotoxane, and alloaromadendrane sesquiterpene glycosides and phenolic glycosides from Dendrobium moniliforme. Journal of Natural Products. 66: 1140-3. PMID 12932145 DOI: 10.1021/Np0301801 |
0.355 |
|
| 2003 |
Zhang D, Halaweish FT. Isolation and identification of foetidissimin: a novel ribosome-inactivating protein from Cucurbita Foetidissima Plant Science. 164: 387-393. DOI: 10.1016/S0168-9452(02)00425-9 |
0.697 |
|
| Show low-probability matches. |